Guangzhou Chroma Lenses Technology Co., Ltd. stands as a titan in the industrial-scale manufacturing of contact lens care solutions and cosmetic lenses. Strategically located in Dongguan, the "World's Factory," our facility represents the pinnacle of Chinese Supply Chain Excellence, merging rapid production cycles with stringent medical-grade quality control.
As a senior B2B growth partner, we understand that "contact lens care product manufacturers" must offer more than just goods—they must provide Reliability (R), Expertise (E), and Information Gain (IG). Our integrated R&D ecosystem ensures that every blister pack, every vial of solution, and every hydrogel lens meets the evolving needs of the global ophthalmic market.
From material compounding (Polyhema/Hydrogel) to final sterilization, our end-to-end process is transparent and data-driven.
Navigating the complex landscape of international medical device regulations is our core expertise. We assist global partners with EUDAMED registration, FDA 510(k) submissions, and localized labeling requirements for diverse markets including Brazil (ANVISA), Korea (MFDS), and the EU (MDR).
By leveraging Dongguan’s unparalleled component ecosystem, we offer shorter lead times (as low as 15 days) compared to European counterparts. Our vertically integrated factory handles everything from monomer synthesis to bespoke box printing and logistics optimization.
Modern B2B sourcing requires more than just low cost. We provide "Turnkey Solutions" for emerging brands, offering flexible MOQ (Minimum Order Quantity), drop-shipping capabilities for e-commerce distributors, and white-label design services that mirror luxury boutique aesthetics.
The industry is shifting towards biocompatible materials and sustained-release hydration technologies. As a leading manufacturer, we are currently pioneering Silicone Hydrogel (SiHy) formulations that offer 5x more oxygen permeability than traditional Polyhema. Additionally, we are integrating Eco-Friendly Packaging initiatives, reducing plastic waste in blister production by 22% through thinner, high-barrier foils.